CD8A and infection: Third, adoptive transfer of polyclonal HCMV-specific T cells is a promising approach to control infection in solid organ and stem cell transplant patients.69 A better understanding of the contributions of different immune effector cells to HCMV control (CD8+ T cells, NK cells, and macrophages) will help identify clinical situations appropriate for antibody versus T cell interventions.